Looks like a tactical retreat, certainly stealthy. Probably much more pronounced than this indicates. Don't be the last short standing. LOL.
Avg Daily Share Volume
Days To Cover
2/12/2016 19,402,587 796,139 24.370854
1/29/2016 23,777,965 1,213,483 19.594807
When the water starts to rise the shorts start squealing like the rats they are. Good time for you to cover instead of complaining. Lol.
Just speculation on my part using logic and the coincidence of the delays following the path of interim and the history of related events between the parties. Seems to be a logical answer. If I were in Amarins situation, in need of capital, and considering what had been done to put them in this situation, when considering that the interim results could very well justify Vascepa ability to do what the FDA said it could not do I would fight very hard to get back what had been taken away, the Anchor label. That represents an additional 30 to 40 million patient population. Why wait until 2018 and the possibility of dilution and or bankruptcy. Fight the good fight when the evidence could very well be on your side at a time when the FDAs arrogance in handling the situation is also evidence of their unjustified intent. Put the stake through the heart of the beast.
Shorts are using a Dark Pool to keep the S/P capped so they can get out without the squeeze. Very professional, but very illegal. Don't give them additional help by giving them cheap shares because we are getting to the point where flipping shares will no longer work well because the S/P is starting to recover gradually which will make it ever more difficult to buy back more shares. The volatility should gradually be turned to the up side. Keep an eye on the trend closely.
Did you report this to NASD or the SEC ?? Market surveillance division ??????
Shorts are using a Dark Pool to keep the S/P capped so they can get out without the squeeze. Very professional, but very illegal. Don't give them additional help by giving them cheap shares because we are getting to the point where flipping shares will no longer work well because the S/P is starting to recover gradually which will make it ever more difficult to buy back more shares. The volatility should gradually be turned to the up side. Keep an eye on the trend closely
The FBI wants you...to contact them:
"The FBI is investigating whether high-speed trading firms trade on non-public information, the Wall Street Journal reports.
The agency is working with the SEC and CFTC.
Bloomberg's Keri Geiger and Patricia Hurtado also have an update:
"The Federal Bureau of Investigation’s inquiry stems from a multiyear crackdown on insider trading, which has led to at least 79 convictions of hedge-fund traders and others. Agents are examining whether traders abuse information to act ahead of orders by institutional investors, according to the person, who asked not to be named because the probe is confidential. Even trades based on computer algorithms could amount to wire fraud, securities fraud or insider trading."
CNBC's Eamon Javers said an FBI spokesman is urging anyone with information about high-frequency trading abuses to call the bureau.
The report comes after Michael Lewis appeared on "60 Minutes" to argue that high-frequency traders have "rigged" the stock market.
That seems to be a starting price if interim reduce it is positive... Something cooking with the FDA and I thinks its in our favor or why would the from exec from Merck join Amarin????
The hiring of an executive from Merck could just as easily be a red herring as it was for Synergy in the hiring of a Shire PLC executive late last year. So that's meaningless.
I also found it difficult to understand how HC Wainright justifies such a rich price target when they expect the study to continue at interim rather than to be stopped early. That makes no sense.
If, on the other hand, they believed as I do that a pre-interim look is already underway which could result in ANCHOR approval, then I could understand their thinking. And yes, I'm aware of what's been said at recent conference calls regarding settlement negotiations not including a label change. Of course they'd say that. My thinking, however, is reinforced by Amarin suggesting that REDUCE-IT won't be stopped early under any circumstances as this would be part of the early look agreement: See a separation; grant ANCHOR; and state only that REDUCE-IT will run to completion.
If I'm right, I'll never be able to prove it as those negotiations will be sealed. If there's no separation, or not enough separation, Amarin will only announce details regarding what can be communicated to physicians about ANCHOR and other relevant studies while stating that REDUCE-IT will continue as planned. Don't think for a second though that I won't be sounding the horn of victory because there's no way an ANCHOR label change would be granted without some kind of look at REDUCE-IT's progress.
Nobody can find any stock in which you weren't 100% wrong. AMRN keeps your streak alive.
centurycom • Buy VALV. Thats all I'm going to say
On Aug 15, 2011 VALV = $4.00 per share
centurycom • Aug 18, 2011 9:33 PM
I am very high on Valv. Think their 10Q will be very revealing and believable.
centurycom • Sep 26, 2011 1:03 AM
"....what makes VALV so special....absoultey nothing...."
I think that is where we differ. Very unique, proven product and one that can actually save a customer money. In these tough ecomonic times, that is a difference maker. Through all of this uncertainty about Chinese companies the cream will rise to the top. Patience will be needed.
Do yourselves a favor very early
by centurycom • Sep 26, 2011 8:01 PM
tomorrow, Buy VALV. Thats all I'm going to say
centurycom • Oct 5, 2011 1:15 PM
I look at fundamentals, cash, product,uniqueness, and management.
You don't make money following the crowd. You make it when they follow you.
Tic tock, tic tock
by centurycom • Oct 5, 2011 9:15 PM
Time running out for shorts.
SYMBOL = VALV
Aug 15, 2011 = $4.00
Aug 13, 2012 = .77
Aug 13, 2013 = .33
Aug 13, 2014 = .28
Jan 15, 2016 = .16
When you eat omega 3 supps like Lovaza, Vascepa and Omega Via, they just get churned, mixed in with all of that everyday junk you eat and digested with all of that food and beverage you. Seems quite obvious to any scientist, but not so much for the idiots out there.
Since the # 1 doctor recommended method for obtaining omega 3s is eating salmon, you can see that 100% of medical doctors do not have any concern with the percentage of omega 3s in each supplement capsule or whether your fish was raised under FDA's cGMP rules.
Not one fish you have ever eaten has been manufactured in a cGMP lab.
You just need to get the proper amount of omega 3s each day and get them in the form your body can use (not ethyl ester).
95% of the world's population can get all the omega 3s they need by eating salmon as recommended by the AHA and 100% of doctors.
Listen to the proven morons (AMRN stock pumpers) at your own peril.
It's a message we'll have to keep posting since the Message Board Management Clerks are back at it.
For those who argue against Omegavia. You have no way to explain why you obsess over the tiniest % of your diet? Even when that tiny percentage of your diet is manufactured in an FDA audited factory and is cGMP certified, yes, I know both Vascepa and Omegavia are both manufactured in an FDA audited factory and both are cGMP certified (FDA standard), but I am talking about Omegavia in this case.
You eat and drink all sorts of garbage each day. More than 99.9% of everything you consume is tainted, polluted, unwashed, grade A garbage. None of which is pharmaceutical grade. None of which is manufactured in an FDA audited facility. None of which is cGMP certified. Most of which could have additives, preservatives, chemicals, pesticides, herbicides, animal feces, insects, human hair and prepared by unwashed hands and runny snot nose cook who isn't feeling so good and brought to you on plates that are hardly clean and you eat with utensils that are nowhere near clean.
But you stay up at night worried about the 4gm of Omegavia that is cGMP certified and manufactured in an FDA audited facility, just like Vascepa. You can't even detect the difference between Omegavia and Vascepa without a science lab yet you just put one pound of ground up cow flesh and poorly washed plant life along with tons of chemical flavoring, additives and preservatives and all of the familiar contaminants found all around you every day.
Use common sense - and science!
The issue with Omega 3 supplements is quality. It may pass cursory inspections at the facility, but what happens as it ships half way across the world is another story. Vascepa has to meet higher mfg standards like any drug that must qualify their facilities but also has to comply with Rx shipping and storage standards that protect it from oxidizing. By the time your OTC fish oil gets to the shelf it could very well be completely worthless from a health standpoint.
When you get a Vascepa prescription you can be assured the regulatory required temperature controlled shipping and storage has maintained the integrity of the drug. Vascepa passes the sniff test. The Reduce-IT trial uses light mineral oil because it has no smell, like Vascepa. I encourage you to smell your OTC EPA supplement. Fishy, isn't it. Rancid? Maybe. Or it's just not pure EPA like they claim.
Most importantly, when you get a Vascepa Rx, you are getting the same quality that was tested in the Rx graded facility. It didn't go rancid in a hot delivery truck or ship. And, because it's an Rx you're getting on a regiment that ensures you consume the proper dose in addition to follow-up with your doctor to monitor your response to the drug and overall health.